588. Lithium and Quetiapine Augmentation Therapy in treatment-resistant depression with atypical features
Abstract Background Treatment-resistant depression (TRD) affects up to half of patients with major depressive disorder and is associated with poorer health outcomes. Lithium and quetiapine are established augmentation strategies in cases of TRD, but there is limited evidence to inform treatment choice in different depr...